Richard Anderson
Stock Analyst at Wedbush
(2.59)
# 2,003
Out of 4,825 analysts
139
Total ratings
100%
Success rate
12.11%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $22 | $17.78 | +23.73% | 5 | Apr 28, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 | $16.18 | +23.61% | 5 | Apr 1, 2025 | |
| NHI National Health Investors | Reiterates: Outperform | $88 | $75.79 | +16.11% | 4 | Mar 17, 2025 | |
| CTRE CareTrust REIT | Reiterates: Underperform | $26 | $28.52 | -8.84% | 3 | Mar 14, 2025 | |
| STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $10.85 | +29.03% | 2 | Mar 5, 2025 | |
| VTR Ventas | Maintains: Outperform | $69 → $78 | $66.46 | +17.36% | 7 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $150.52 | +10.95% | 5 | Feb 14, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $17.84 | +12.11% | 4 | Jan 13, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $14.49 | +44.98% | 2 | Jan 2, 2025 | |
| HR Healthcare Realty Trust | Downgrades: Underperform | $18 → $16 | $15.23 | +5.06% | 8 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $65.04 | +7.63% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $31.70 | +4.12% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $61.66 | +16.77% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $74.45 | +47.75% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $167.05 | +25.11% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $35.32 | +13.27% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $114.83 | +14.08% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $71.77 | +4.50% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $291.55 | +3.24% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $43.80 | +11.88% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $33.87 | +32.86% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $26.56 | +24.25% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $167.69 | +9.73% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $14.80 | +48.70% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $10.28 | +65.45% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $47.19 | +8.07% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $49.04 | -0.08% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $34.33 | +31.08% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $57.59 | +16.34% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.25 | +233.33% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $93.51 | +0.52% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $9.14 | +53.17% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $17.42 | -8.15% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $37.04 | -8.21% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $212.11 | -15.61% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.68 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.24 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.06 | - | 2 | Jul 10, 2017 |
Healthpeak Properties
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $22
Current: $17.78
Upside: +23.73%
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $16.18
Upside: +23.61%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $75.79
Upside: +16.11%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $28.52
Upside: -8.84%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $10.85
Upside: +29.03%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $66.46
Upside: +17.36%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $150.52
Upside: +10.95%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $17.84
Upside: +12.11%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $14.49
Upside: +44.98%
Healthcare Realty Trust
Jan 2, 2025
Downgrades: Underperform
Price Target: $18 → $16
Current: $15.23
Upside: +5.06%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $65.04
Upside: +7.63%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $31.70
Upside: +4.12%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $61.66
Upside: +16.77%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $74.45
Upside: +47.75%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $167.05
Upside: +25.11%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $35.32
Upside: +13.27%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $114.83
Upside: +14.08%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $71.77
Upside: +4.50%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $291.55
Upside: +3.24%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $43.80
Upside: +11.88%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $33.87
Upside: +32.86%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $26.56
Upside: +24.25%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $167.69
Upside: +9.73%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $14.80
Upside: +48.70%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $10.28
Upside: +65.45%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $47.19
Upside: +8.07%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $49.04
Upside: -0.08%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $34.33
Upside: +31.08%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $57.59
Upside: +16.34%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.25
Upside: +233.33%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $93.51
Upside: +0.52%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $9.14
Upside: +53.17%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $17.42
Upside: -8.15%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $37.04
Upside: -8.21%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $212.11
Upside: -15.61%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $4.68
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $8.24
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.06
Upside: -